iconEarnings Announcement After Market Close

Enanta Pharmaceuticals Inc ENTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/05/22 EDT
70.96UNCH (UNCH)
Volume
1,442
Close
70.96quote price arrow up+2.87 (+4.22%)
Volume
218,265
52 week range
37.59 - 102.00
Loading...
  • Open67.44
  • Day High71.11
  • Day Low66.90
  • Prev Close70.96
  • 52 Week High102.00
  • 52 Week High Date11/05/21
  • 52 Week Low37.59
  • 52 Week Low Date05/27/22

Key Stats

  • Market Cap1.47B
  • Shares Out20.71M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change-5.11

KEY STATS

  • Open67.44
  • Day High71.11
  • Day Low66.90
  • Prev Close70.96
  • 52 Week High102.00
  • 52 Week High Date11/05/21
  • 52 Week Low37.59
  • 52 Week Low Date05/27/22
  • Market Cap1.47B
  • Shares Out20.71M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change-5.11

RATIOS/PROFITABILITY

  • EPS (TTM)-5.52
  • P/E (TTM)-12.86
  • Fwd P/E (NTM)12.15
  • EBITDA (TTM)-128.599M
  • ROE (TTM)-28.27%
  • Revenue (TTM)91.56M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-122.68%
  • Debt To Equity (MRQ)0.42%

EVENTS

  • Earnings Date08/08/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Enanta Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Enanta Pharmaceuticals, Inc. is a biotechnology company. The Company is engaged in development of small molecule drugs for the treatment of viral infections and liver diseases. The Company has clinical candidates for the disease targets, including respiratory syncytial virus (RSV), hepatitis B virus (HBV) and non-alcoholic steatohepatitis (NASH). The Company has discovered glecaprevir, a protease inhibitor discovered and developed for the treatment of chronic hepatitis C...
Bruce Carter Ph.D.
Independent Non-Executive Chairman of the Board
Jay Luly Ph.D.
President, Chief Executive Officer, Director
Paul Mellett Jr.
Chief Financial Officer, Senior Vice President - Finance and Administration
Address
500 Arsenal Street
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
RVNC
Revance Therapeutics Inc
19.65+1.35+7.38%
BBIO
BridgeBio Pharma Inc
11.19+1.21+12.12%
VCEL
Vericel Corp
30.77+0.34+1.12%
KYMR
Kymera Therapeutics Inc
31.17+3.04+10.81%
PACB
Pacific Biosciences of California Inc
6.06+0.25+4.30%